Outcomes and Long-term Follow-up of Epithelial Ovarian Cancer: Experience from the Lead Cancer Center of Pakistan
References
- Ikram A, Pervez S, Khadim MT, Sohaib M, Uddin H, Badar F, et al. National Cancer Registry of Pakistan: First Comprehensive Report of Cancer Statistics 2015–2019. J Coll Physicians Surg Pak. 2023;33(6):625–32. doi: 10.29271/jcpsp.2023.06.625
- Lacey JV Jr, Sherman ME. Ovarian neoplasia. In: Robboy SL, Mutter GL, Prat J, et al., editors. Robboy’s Pathology of the Female Reproductive Tract. 2nd ed. Oxford: Churchill Livingstone Elsevier; 2009. p. 601.
- Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1–5.
- Harrison ML, Cameson C, Gore ME. Mucinous ovarian cancer. Int J Gynaecol Obstet. 2008;103(2):209–14.
- Ali NSI, Sayyed NRH, Akbar NSA, Abubakar NM, Syed NAA, Admin N. Retrospective study of ovarian malignancy managed in surgical unit at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore. J Pak Med Assoc. 2020;71(2 Pt B):1–9. doi: 10.47391/jpma.07-727
- Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129(1):258–64.
- Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994;170(4):974–80. doi: 10.1016/s0002-9378(94)70090-7
- Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, et al. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol. 1991;9(3):389–93. doi: 10.1200/jco.1991.9.3.389
- Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–7. doi: 10.1002/cncr.22371. PMID: 17154394.
- Bankhead C, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG. 2008;115(8):1008–14. doi: 10.1111/j.1471-0528.2008.01772.x
- Perveen H, Haider G, Kerio P, Zahoor S, Mahar K, Memon P. Association between Histopathologic Type of Ovarian Cancer and Serum CA-125 Level. Pak Armed Forces Med J. 2023;73(Suppl-1):S102–5. doi: 10.51253/pafmj.v73isuppl-1.5410
- Zhang Y, Luo G, Li M, Guo P, Xiao Y, Ji H, et al. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. BMC Cancer. 2019;19(1):984. doi: 10.1186/s12885-019-6139-6
- Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460(3):237–49. doi: 10.1007/s00428-012-1203-5
- Hannibal CG, Vang R, Junge J, Kjaerbye-Thygesen A, Kurman RJ, Kjaer SK. A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006. Gynecol Oncol. 2012;125(3):655–60. doi: 10.1016/j.ygyno.2012.02.028
- Sarwar CM, Siddiqui N, Khokhar RA, Badar F. Epithelial ovarian cancer at a cancer hospital in a developing country. Asian Pac J Cancer Prev. 2006;7(4):595–8. PMID: 17250434.
- Khan A, Sultana K. Presenting signs and symptoms of ovarian cancer at a tertiary care hospital. J Pak Med Assoc. 2010;60(4):260–2. PMID: 20419965.
- Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188503. doi: 10.1016/j.bbcan.2021.188503
- Li Z, Wang J, Zhang Y, Yang Z, Zhou F, Bai X, et al. Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models. Front Oncol. 2025;15:1592746. doi: 10.3389/fonc.2025.1592746
- Rosenthal AN, Menon U, Jacobs IJ. Screening for ovarian cancer. Clin Obstet Gynecol. 2006;49(3):433–47. doi: 10.1097/00003081-200609000-00004
- Braicu E, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C. Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer. 2011;105(12):1818–24. doi: 10.1038/bjc.2011.455
- Zhou J, Wu S, Wang J, Sun J, He Z, Jin X, et al. The effect of histological subtypes on outcomes of Stage IV epithelial ovarian cancer. Front Oncol. 2018;8:577. doi: 10.3389/fonc.2018.00577
- Wu S, Wang J, Sun J, He Z, Zhang W, Zhou J. Real-World impact of survival by period of diagnosis in epithelial ovarian cancer between 1990 and 2014. Front Oncol. 2019;9:639. doi: 10.3389/fonc.2019.00639
- van Nagell JR, Burgess BT, Miller RW, Baldwin L, DeSimone CP, Ueland FR, et al. Survival of women with type I and II epithelial ovarian cancer detected by ultrasound screening. Obstet Gynecol. 2018;132(5):1091–100. doi: 10.1097/aog.0000000000002921
- Hoff J, Baldwin L, Lefringhouse J, Pavlik E, Miller R, DeSimone C, et al. Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer. J Oncol. 2014;2014:312193. doi: 10.1155/2014/312193
- Vijaykumar D, Viral P, Rajanbabu A, Pavithran K, Chithrathara K, Nair I, et al. Long-term survival outcome of advanced epithelial ovarian cancer: A single institutional study. Indian J Cancer. 2021;58(3):342–9. doi: 10.4103/ijc.ijc_165_19
- Alam I, Waqar F, Khan A, Begum N. Prevalence and management of ovarian tumors in Women and Children Hospital, Abbottabad. J Ayub Med Coll Abbottabad. 2001;13(1):19–21.
- Arai M, Utsunomiya J, Miki Y. Familial breast and ovarian cancers. Int J Clin Oncol. 2004;9(4):270–82.
DOI: https://doi.org/10.2478/jcas-2026-0014 | Journal eISSN: 2411-989X
Language: English
Page range: 105 - 113
Published on: Sep 1, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2026 Jamshed Ali, Mahnoor Raza, Muhammad Umer Khayyam Azam, Farhana Badar, Junaid Khan, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.